SkinBioTherapeutics (SBTX)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

 16.75p
   
  • Change Today:
      0.000p
  • 52 Week High: 26.10p
  • 52 Week Low: 10.38p
  • Currency: UK Pounds
  • Shares Issued: 258.78m
  • Volume: 223,348
  • Market Cap: £43.35m
  • Beta: 0.01

Growth Ratings

EPS Growth shows the relative growth of a company's earnings over the last year.

The rise in total monies receivable for goods / services sold before expenses.

1yr EPS Growth Not Available
1yr Revenue Growth
98.50% above the market average98.50% above the market average98.50% above the market average98.50% above the market average98.50% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average

Income Ratings

The percentage of the share price that a company pays out as dividends over a year.

The percentage change from the previous year in the dividend paid on each share.

Dividend Yield Not Available
1yr DPS Growth Not Available

Valuation Ratings

The share price as a ratio of revenue per share.

The share price as a ratio of net asset value.

Price Sales Ratio
68.89% above the market average68.89% above the market average68.89% above the market average68.89% above the market average68.89% above the market average
66.67% above the sector average66.67% above the sector average66.67% above the sector average66.67% above the sector average66.67% above the sector average
Price Book Ratio
94.75% below the market average94.75% below the market average94.75% below the market average94.75% below the market average94.75% below the market average
78.38% below the sector average78.38% below the sector average78.38% below the sector average78.38% below the sector average78.38% below the sector average

Performance Ratings

In percentage total change in share price over 30 days.

In percentage total change in share price over 3 months.

Price Chg 30d
28.48% above the market average28.48% above the market average28.48% above the market average28.48% above the market average28.48% above the market average
24.44% above the sector average24.44% above the sector average24.44% above the sector average24.44% above the sector average24.44% above the sector average
Price Chg 3m
88.74% below the market average88.74% below the market average88.74% below the market average88.74% below the market average88.74% below the market average
77.78% below the sector average77.78% below the sector average77.78% below the sector average77.78% below the sector average77.78% below the sector average

Technical Ratings

The Relative Strength Index measures a share price relative to itself and its recent history.

Momentum is an oscillator that measures the rate of price change.

RSI
39.00% above the market average39.00% above the market average39.00% above the market average39.00% above the market average39.00% above the market average
31.71% above the sector average31.71% above the sector average31.71% above the sector average31.71% above the sector average31.71% above the sector average
Momentum 20
20.09% above the market average20.09% above the market average20.09% above the market average20.09% above the market average20.09% above the market average
26.83% above the sector average26.83% above the sector average26.83% above the sector average26.83% above the sector average26.83% above the sector average

Management Ratings

Operating Margin is profit as a percentage of sales.

Return on capital employed measures the return from invested and borrowed capital.

Operating Margin
84.71% below the market average84.71% below the market average84.71% below the market average84.71% below the market average84.71% below the market average
40% below the sector average40% below the sector average40% below the sector average40% below the sector average40% below the sector average
ROCE Not Available

Profitability Ratings

Earnings per share, the company's profitability expressed on a per share basis.

Analysts' estimates of future EPS for the next 2 years.

EPS
63.13% below the market average63.13% below the market average63.13% below the market average63.13% below the market average63.13% below the market average
40.91% below the sector average40.91% below the sector average40.91% below the sector average40.91% below the sector average40.91% below the sector average
Forecast EPS Not Available

Profit/Loss Ratings

Monies produced from sales of goods and services after trade discounts, VAT, etc.

Operating Profit is the profit after deducting operating costs from gross profits.

Turnover
78.98% below the market average78.98% below the market average78.98% below the market average78.98% below the market average78.98% below the market average
40% below the sector average40% below the sector average40% below the sector average40% below the sector average40% below the sector average
Operating Profit Loss
64.16% below the market average64.16% below the market average64.16% below the market average64.16% below the market average64.16% below the market average
9.09% below the sector average9.09% below the sector average9.09% below the sector average9.09% below the sector average9.09% below the sector average

Balance Sheet Ratings

The difference between current assets and current liabilities.

A current asset representing the company's financial liquidity.

Assets
74.76% below the market average74.76% below the market average74.76% below the market average74.76% below the market average74.76% below the market average
51.22% below the sector average51.22% below the sector average51.22% below the sector average51.22% below the sector average51.22% below the sector average
Cash
62.62% below the market average62.62% below the market average62.62% below the market average62.62% below the market average62.62% below the market average
48.84% below the sector average48.84% below the sector average48.84% below the sector average48.84% below the sector average48.84% below the sector average

Director Deal Ratings

The cumulative amount of stocks sold by company directors over 1 year

The cumulative amount of stocks bought by company directors over 1 year

Sells 1y Not Available
Buys 1y Not Available

Broker Ratings

The percentage of stockbrokers that rate the company as a Buy

The percentage of stockbrokers that rate the company as a Hold

Brokers Percent Buy Not Available
Brokers Percent Neutral Not Available

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

SBTX Market Data

Currency UK Pounds
Share Price 16.75p
Change Today 0.000p
% Change 0.00 %
52 Week High 26.10p
52 Week Low 10.38p
Volume 223,348
Shares Issued 258.78m
Market Cap £43.35m
Beta 0.01

SBTX Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
71.12% below the market average71.12% below the market average71.12% below the market average71.12% below the market average71.12% below the market average
90.7% below the sector average90.7% below the sector average90.7% below the sector average90.7% below the sector average90.7% below the sector average
Price Trend
48.75% above the market average48.75% above the market average48.75% above the market average48.75% above the market average48.75% above the market average
73.33% above the sector average73.33% above the sector average73.33% above the sector average73.33% above the sector average73.33% above the sector average
Income Not Available
Growth
49.76% above the market average49.76% above the market average49.76% above the market average49.76% above the market average49.76% above the market average
73.33% above the sector average73.33% above the sector average73.33% above the sector average73.33% above the sector average73.33% above the sector average

SBTX Dividends

No dividends found

Trades for 01-Aug-2025

Time Volume / Share Price
16:17 35,071 @ 17.00p
16:02 7,976 @ 16.63p
15:02 10,000 @ 16.63p
13:53 35,071 @ 16.70p
12:33 11,827 @ 16.63p

SBTX Key Personnel

CEO Stuart Ashman
CFO Manprit Singh Randhawa

Top of Page